Skip to main content

US ClosedU.S. Closed

RNAC: Cartesian Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Cartesian Therapeutics, Inc. , a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases.

52W Range

74thpctl

Volume

0.27×avg

Market Cap

282.06MUSD

P/E Ratio

-1.6TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Cartesian Therapeutics, Inc.

RNACNASDAQ·USD·Closed

Cartesian Therapeutics, Inc.

RNACNASDAQ·USD·Closed

$9.60

−3.71%

$9.60

−$0.37 (3.71%)

52W Range

74thpctl

Volume

0.27×avg

Mkt Cap

282.06MUSD

P/E

-1.6TTM

Div Yield

–ann